Arkolith/Insider Trading/NTLA/Form 4

Goodman Jesse

DirectorIntellia Therapeutics, Inc. (NTLA) · full profile →Form 4 · filed Jul 2, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$29K
Net Open-Market Flow
-$29K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 1, 2025Sell(S)2K$9.23$14K24K
Jun 30, 2025Sell(S)2K$9.56$15K26K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-093302) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML